Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease

Erman Bozali, (Sivas Cumhuriyet Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Sivas, Türkiye)
Haydar Erdogan, (Sivas Cumhuriyet Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Sivas, Türkiye)
Ayhan Dursun, (Ankara Maya Göz Hastanesi, Ankara, Türkiye)
Ayse Vural Ozec, (Sivas Cumhuriyet Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Sivas, Türkiye)
Mustafa Ilker Toker, (Sağlık Bilimleri Üniversitesi, Ulucanlar Göz Eğitim ve Araştırma Hastanesi, Ankara, Türkiye)
Mustafa Kemal Aric (Memorial Ataşehir Hastanesi, İstanbul, Türkiye)
Clinical and Experimental Health Sciences
0 0
Yıl: 2021 Cilt: 11 Sayı: 2 Sayfa Aralığı: 296 - 301 Metin Dili: İngilizce DOI: 10.33808/clinexphealthsci.764833 İndeks Tarihi: 13-01-2022

Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease

Öz:
Objective: To evaluate the foveal thickness and macular choroidal thickness on patients who were diagnosed with Behcet’s Disease (BD). Methods: A total of 60 patients were included in this prospective cross-sectional study. Patients were divided into two groups. Group 1 consisted of 30 patients who were diagnosed with BD and Group 2 consisted of 30 healthy controls. Detailed ophthalmological examination was performed on both groups and foveal thickness and macular choroidal thickness were measured with Spectral-Domain Optical Coherence Tomography (SD-OCT). To measure the choroidal thickness enhanced depth imaging OCT (EDI-OCT) technique was used. Results: Mean foveal thickness in BD patients was 216.06 ± 53.14 μm and mean subfoveal choroidal thickness was 363.21 ± 85.22 μm. Mean foveal thickness and subfoveal choroidal thickness in healthy controls was 211.65 ± 16.60 μm and 352.83 ± 87.11 μm respectively. There was no statistical significance between patients with BD and patients of the control group regarding foveal and subfoveal choroidal thickness. However, anatomical deformation of Ellipsoid Zone structure in OCT had the most effect on visual acuity (p=0.001). Conclusion: This study shows that there was no statistically significant difference in terms of foveal thickness and macular choroidal thickness in patients with BD.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Behcet H. Uber rezidivierende, aphthose, durchein Virus verusachte Gaschwure am Mund, am Auge und an den Genitalien. Dermat Wochsch 1937;105:1152-1157.
  • [2] Mittal A, Velaga SB, Falavarjani KG, Nittala MG, Sadda SR. Choroidal thickness in non-ocular Behçet’s disease – A spectraldomain OCT study. J Curr Ophthalmol 2017;29(3):210-213.
  • [3] Charteris D, Barton K, McCartney A, Lightman S. CD4+ Lymphocyte Involvement in Ocular Behcet’s Disease. Autoimmunity 1992;12(3):201-206.
  • [4] Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J 1997;38(6):423-427.
  • [5] Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol 2007;91(12):1579-1582.
  • [6] Özdal P, Ortac S, Taşkintuna I, Firat E. Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol 2002;12(5):424-431.
  • [7] Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138(3):373-380.
  • [8] Kim HB. Ophthalmologic manifestation of Behçet’s disease. Yonsei Med J 1997;38(6):390-394.
  • [9] Atmaca L, Sonmez P. Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol 2003;87(12):1466-1468.
  • [10] Gedik Ş, Akova YA, Yilmaz G, Bozbeyoğlu S. Indocyanine Green and Fundus Fluorescein Angiographic Findings in Patients with Active Ocular Behçet’s Disease. Ocul Immunol Inflamm 2005;13(1):51-58.
  • [11] Kansu T, Kadayifcilar S. Visual aspects of Behçet’s disease. Curr Neurol Neurosci Rep 2005;5(5):382-388.
  • [12] Klaeger AJ, Tran VT, Hiroz CA, Morisod L, Herbort CP. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behcet’s uveitis. Int Ophthalmol 2004;25(1):57-63.
  • [13] Tekeli O, Özdemir Ö. Heidelberg retina tomograph in ocular Behçet’s disease. Eye 2004;18(2):143-146.
  • [14] Alm A, Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 1973;15(1):15-29.
  • [15] Laviers H, Zambarakji H. Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefe’s Archive for Clinical and Experimental Ophthalmology 2014;252(12):1871- 1883.
  • [16] Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011;118(5):840-845.
  • [17] Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148(3):445-450.
  • [18] Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29(10):1469-1473.
  • [19] Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147(5):811-815.
  • [20] Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, Nishida K. Choroidal observations in Vogt–Koyanagi–Harada disease using high-penetration optical coherence tomography. Graefe’s Archive for Clinical and Experimental Ophthalmology 2012;250(7):1089-1095.
  • [21] Park UC, Cho IH, Moon SW, Yu HG. Long-term change of subfoveal choroidal thickness in Behçet’s Disease patients with posterior uveitis. Ocul Immunol Inflamm 2018;26(3):397-405.
  • [22] Criteria for diagnosis of Behçet’s Disease. International study group for Behcet’s disease. Lancet 1990;335(8697):1078-1080.
  • [23] Yazici H, Başaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, Tüzün Y, Özyazgan Y, Dimitriyadis I. The ten-year mortality in Behçet’s syndrome. Rheumatology 1996;35(2):139-141.
  • [24] Alwassia AA, Adhi M, Zhang JY, Regatieri CV, Al-Quthami A, Salem D, Fujimoto JG, Duker JS. Exercise-induced acute changes in systolic blood pressure do not alter choroidal thickness as measured by a portable spectral-domain optical coherence tomography device. Retina 2013;33(1):160.
  • [25] Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology 2011;249(8):1123-1128.
  • [26] Brown JS, Flitcroft DI, Ying G-s, Francis EL, Schmid GF, Quinn GE, Stone RA. In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci 2009;50(1):5-12.
  • [27] Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53(1):261-266.
  • [28] Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC. Choroidal thickness in Behcet’s uveitis: an enhanced depth imagingoptical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci 2013;54(9):6033-6039.
  • [29] Coskun E, Gurler B, Pehlivan Y, Kisacik B, Okumus S, Yayuspayı R, Ozcan E, Onat AM. Enhanced depth imaging optical coherence tomography findings in Behcet disease. Ocul Immunol Inflamm 2013;21(6):440-445.
  • [30] Takeuchi M, Iwasaki T, Kezuka T, Usui Y, Okunuki Y, Sakai Ji, Goto H. Functional and morphological changes in the eyes of Behcet’s patients with uveitis. Acta Ophthalmol (Copenh) 2010;88(2):257-262.
  • [31] Landa G, Gentile RC, Garcia PM, Muldoon TO, Rosen RB. External limiting membrane and visual outcome in macular hole repair: spectral domain OCT analysis. Eye (Lond) 2012;26(1):61-69.
  • [32] Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourierdomain optical coherence tomography. Ophthalmology 2009;116(3):519-528.
  • [33] Domalpally A, Peng Q, Danis R, Blodi B, Scott IU, Ip M. Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13. Eye (Lond) 2012;26(7):919-924.
  • [34] Unoki N, Nishijima K, Kita M, Hayashi R, Yoshimura N. Structural changes of fovea during remission of Behçet’s disease as imaged by spectral domain optical coherence tomography. Eye 2010;24(6):969-975.
  • [35] Guyer D, Schachat A, and Green W. The choroid: structural considerations. Retina 2006;4(1):33-42.
  • [36] Karampelas M, Sim DA, Keane PA, Zarranz-Ventura J, Patel PJ, Tufail A, Westcott M, Lee R, Pavesio CE. Choroidal assessment in idiopathic panuveitis using optical coherence tomography. Graefe’s Archive for Clinical and Experimental Ophthalmology, 2013;251(8):2029-2036.
  • [37] Iaccarino G, Cennamo G, Forte R, Cennamo G. Evaluation of posterior pole with echography and optical coherence tomography in patients with Behçet’s disease. Ophthalmologica 2009;223(4):250-255.
  • [38] Charteris DG, Champ C, Rosenthal AR, Lightman SL. Behçet’s disease: activated T lymphocytes in retinal perivasculitis. Br J Ophthalmol 1992;76(8):499-501.
  • [39] George RK, Chan C-C, Whitcup SM, Nussenblatt RB. Ocular immunopathology of Behçet’s disease. Surv Ophthalmol 1997;42(2):157-162.
  • [40] Mullaney J, Collum L. Ocular vasculitis in Behçet’s disease. Int Ophthalmol 1985;7(3-4):183-191.
  • [41] Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, Accorinti M, Pivetti-Pezzi P. Indocyanine green angiographic findings in Behçet disease. Retina 2001;21(3):230-236.
  • [42] Matsuo T, Sato Y, Shiraga F, Shiragami C, and Tsuchida Y. Choroidal abnormalities in Behçet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology 1999;106(2):295-300.
  • [43] Herbort CP, LeHoang P, Guex-Crosier Y. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology 1998;105(3):432-440.
  • [44] Matsuda N, Ogura Y, Nishiwaki H, Miyamoto K, Matsubara T, Kiryu J, Honda Y. Visualization of leukocyte dynamics in the choroid with indocyanine green. Invest Ophthalmol Vis Sci 1996;37(11):2228-2233.
  • [45] Klaeger A, Tran TV, Hiroz C-A, Morisod L, Herbort CP. Indocyanine green angiography in Behçet’s uveitis. Retina 2000;20(3):309-314.
  • [46] Akçar N, Göktekin F, Özer A, Korkmaz C. Doppler sonography of ocular and carotid arteries in Behçet patients. J Clin Ultrasound 2010;38(9):486-492.
  • [47] Kim M, Kim SS, Kwon HJ, Koh HJ, Lee SC. Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci 2012;53(12):7710-7717.
APA Bozali E, Erdogan H, DURSUN A, Vural özeç A, TOKER M, arici m (2021). Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. , 296 - 301. 10.33808/clinexphealthsci.764833
Chicago Bozali Erman,Erdogan Haydar,DURSUN AYHAN,Vural özeç Ayşe,TOKER MUSTAFA ILKER,arici mustafa kemal Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. (2021): 296 - 301. 10.33808/clinexphealthsci.764833
MLA Bozali Erman,Erdogan Haydar,DURSUN AYHAN,Vural özeç Ayşe,TOKER MUSTAFA ILKER,arici mustafa kemal Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. , 2021, ss.296 - 301. 10.33808/clinexphealthsci.764833
AMA Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. . 2021; 296 - 301. 10.33808/clinexphealthsci.764833
Vancouver Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. . 2021; 296 - 301. 10.33808/clinexphealthsci.764833
IEEE Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m "Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease." , ss.296 - 301, 2021. 10.33808/clinexphealthsci.764833
ISNAD Bozali, Erman vd. "Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease". (2021), 296-301. https://doi.org/10.33808/clinexphealthsci.764833
APA Bozali E, Erdogan H, DURSUN A, Vural özeç A, TOKER M, arici m (2021). Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences, 11(2), 296 - 301. 10.33808/clinexphealthsci.764833
Chicago Bozali Erman,Erdogan Haydar,DURSUN AYHAN,Vural özeç Ayşe,TOKER MUSTAFA ILKER,arici mustafa kemal Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences 11, no.2 (2021): 296 - 301. 10.33808/clinexphealthsci.764833
MLA Bozali Erman,Erdogan Haydar,DURSUN AYHAN,Vural özeç Ayşe,TOKER MUSTAFA ILKER,arici mustafa kemal Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences, vol.11, no.2, 2021, ss.296 - 301. 10.33808/clinexphealthsci.764833
AMA Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences. 2021; 11(2): 296 - 301. 10.33808/clinexphealthsci.764833
Vancouver Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences. 2021; 11(2): 296 - 301. 10.33808/clinexphealthsci.764833
IEEE Bozali E,Erdogan H,DURSUN A,Vural özeç A,TOKER M,arici m "Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease." Clinical and Experimental Health Sciences, 11, ss.296 - 301, 2021. 10.33808/clinexphealthsci.764833
ISNAD Bozali, Erman vd. "Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease". Clinical and Experimental Health Sciences 11/2 (2021), 296-301. https://doi.org/10.33808/clinexphealthsci.764833
Sayfa Oluşturulma Tarihi
24-04-2024 14:32

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları